Upsurge Labs cancels Bengaluru peptide event after Karnataka FSDA seeks product details

Upsurge Labs LLP called off its Bengaluru peptide wellness event a day before it was due to take place after Karnataka’s food-safety regulator sought information on products planned for promotion, signalling tighter scrutiny of experimental wellness claims.

— Source publishedSat, 29 Aug, 2026, 11:32 IST·First seen Sat, 29 Aug, 2026, 12:39 IST·Source NDTV Profit

What happened

Upsurge Labs LLP cancelled its Bengaluru peptide wellness event after Karnataka FSDA sought details on products planned for promotion. The episode highlights

Key facts

  • August 29
  • 0% to 190% of labelled active-ingredient claims

Why this matters

Screen peptide-wellness partnership or acquisition targets for defensible claims, clear compliance ownership and the ability to operate through stricter Indian regulatory review.

What to watch

  • Karnataka FSDA issues a notice, seizure, stop-sale direction, public advisory, or clarification following its request for details.
  • FSSAI, CDSCO, or state drug-control authorities comment on peptide supplements, injectable peptides, compounded products, or health claims.
  • Other Indian cities cancel peptide, longevity, biohacking, or hormone-wellness events.
  • Major marketplaces remove peptide listings or require additional seller documentation.
  • Influencers and clinics delete before-and-after, weight-loss, anti-ageing, fertility, metabolic, or therapeutic peptide claims.
  • A documented adverse-event report, consumer complaint, or enforcement action links a marketed peptide product to safety concerns.
  • Pause or revise event-led peptide promotions until product classification, ingredient documentation, import records, labels, and claims substantiation are reviewed.
  • Separate general wellness messaging from disease-treatment, hormonal, anti-ageing, injectable, body-composition, and performance-enhancement claims.
  • Prepare a regulator-ready dossier covering formulation, manufacturer, FSSAI or drug-related approvals where applicable, safety evidence, batch testing, and promotional materials.
  • Shift marketing budgets toward compliant adjacent categories such as protein, recovery nutrition, sleep, skin health, and clinician-supervised diagnostics.
  • Monitor competitor cancellations, product-page edits, influencer disclosure changes, and practitioner partnership activity for signs of category-wide retrenchment.